10-12-3　ⓔ文献

  1. Siegelman SS, Khouri NF, et al: Pulmonary hamartoma: CT findings. Radiology, 1986; 160: 313–317.

  2. Corrin B, Nicholson AG, eds: Pathology of the Lungs, 3rd ed, Churchill Livingstone, Elsevier, 2011; 626–627.

  3. von Ahsen I, Rogalla P, et al: Expression patterns of the LPP–HMGA2 fusion transcript in pulmonary chondroid hamartomas with t (3;12) (q27 approximately 28;q14 approximately 15). Cancer Genet Cytogenet, 2005; 163: 68–70.

  4. Basile A, Gregoris A, et al: Malignant change in a benign pulmonary hamartoma. Thorax, 1989; 44: 232–233.

  5. Ribet M, Jaillard–Thery S, et al: Pulmonary hamartoma and malignancy. J Thorac Cardiovasc Surg, 1994; 107: 611–614．

  6. Hansen CP, Holtveg H, et al: Pulmonary hamartoma. J Thorac Cardiovasc Surg, 1992; 104: 674–678.

  7. Yildirim BB, Karalezli A, et al: Endobronchial hamartoma. J Bronchology Interv Pulmonol, 2011; 18: 355–358.

  8. Travis WD, Brambilla E, eds: World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. International Agency for Research on Cancer (IARC), IARC press, 2004.

  9. Roden AC, Hu X, et al: BRAF V600E expression in Langerhans cell histiocytosis: clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases. Am J Surg Pathol, 2014; 38: 548–551.

  10. 杉本親寿，井上義一：肺ランゲルハンス細胞組織球症．呼吸，2011; 30: 57–62.